Message aux signatairesAllow AHSCT treatment for patients with Multiple Sclerosis in America

Debate: Non-myeloablative HSCT should be offered as a firstline DMT - MS Cutting Edge Science

Timothy PFremont, MI, États-Unis
6 mars 2023

https://neurologyacademy.org/articles/debate-non-myeloablative-hsct-should-be-offered-as-a-firstline-dmt-ms-cutting-edge-science

Copier le lien
Facebook
WhatsApp
X
E-mail